Walleye Trading LLC Innoviva, Inc. Put Options Transaction History

Walleye Trading LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	SELL	$15.91 - $18.72 $111,370 - $131,039	-7,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$13.06 - $17.24 $91,420 - $120,679	7,000 New	7,000 $117,000
Q2 2019 Aug 14, 2019	SELL	$13.1 - $14.95 $6,550 - $7,475	-500 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$13.69 - $20.06 $320,346 - $469,403	-23,400 Reduced 97.91%	500 $7,000
Q4 2018 Feb 14, 2019	BUY	$13.96 - $18.26 $178,688 - $233,728	12,800 Added 115.32%	23,900 $417,000
Q3 2018 Nov 14, 2018	BUY	$13.63 - $15.7 $151,293 - $174,270	11,100 New	11,100 $169,000
Q3 2017 Nov 14, 2017	SELL	$12.06 - $14.12 $145,926 - $170,852	-12,100 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	12,100	12,100 $156,000

227

78.9M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.24B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.